Product image of Xanaflu Tetra Saison 2024/2025 (B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Austria/1359417/202) supplied by GNH India

Xanaflu Tetra Saison 2024/2025

Active Ingredient:
B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Austria/1359417/202
Origin:
EU

Xanaflu Tetra Saison 2024/2025 (B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Austria/1359417/202)

Xanaflu Tetra Saison 2024/2025 is a quadrivalent influenza vaccine designed to protect against four influenza virus strains. It is administered via intramuscular or subcutaneous injection for seasonal flu prevention. This vaccine is suitable for adults and children aged 6 months and older. Always consult a healthcare provider for personalized advice.

Manufacturer / TM Owner

Viatris Healthcare Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xanaflu Tetra Saison 2024/2025 is used to help prevent influenza, commonly known as the flu. It protects against four influenza virus strains, including two influenza A and two influenza B viruses. The vaccine is updated annually to match circulating flu viruses. It is recommended for individuals seeking seasonal flu protection.

Side Effects

  • After vaccination, the body develops immunity to the influenza viruses contained in the vaccine. This immunity helps reduce the risk of contracting the flu or experiencing severe symptoms if infected. Common effects may include mild soreness at the injection site or low-grade fever. These effects are generally temporary and indicate the body’s immune response.

Precautions & Warnings

  • Store the vaccine at 2°C to 8°C and protect it from light. Do not freeze. Before administration, check the vaccine vial for any discoloration or particles. Ensure the vaccine is administered by a healthcare professional. Inform your healthcare provider of any allergies or medical conditions prior to vaccination.

Avoid Interactions

  • Xanaflu Tetra Saison 2024/2025 may interact with immunosuppressive therapies, reducing its effectiveness. Avoid receiving the vaccine if you have a severe fever or acute illness. Discuss any recent vaccinations or medications with your healthcare provider. Live vaccines should not be administered within 4 weeks of this vaccine.

Frequently Asked Questions

It is used to help prevent influenza, or the flu, by protecting against four influenza virus strains.

It is administered via intramuscular or subcutaneous injection by a healthcare professional.

It is recommended for adults and children aged 6 months and older seeking seasonal flu protection.

Common effects may include mild soreness at the injection site or low-grade fever.

Inform your healthcare provider of any allergies before receiving the vaccine to ensure safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Austria/1359417/202

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT